PURPOSE: Interleukin-4 (IL-4) and interleukin-13 (IL-13) are anti-inflammatory and immunomodulatory cytokines which can influence cancer-directed immunosurveillance. Nothing is presently known about expression of these cytokines and their receptors (IL-4R and IL-13R) in colorectal cancer. The aim of this study was to characterize their expression in primary colorectal cancer specimens and to evaluate possible functions for this disease. METHODS: Expression of IL-4, IL-13, IL-4R, and IL-13R protein was characterized by immunohistochemistry in 359 patients with Union for International Cancer Control stage I-III colorectal cancer and evaluated by uni- and multivariate analysis for their prognostic relevance. RESULTS: All four proteins were expressed in colorectal cancer specimens. In the cancer cells, high IL-4, IL-13, IL-4R, and IL-13R immunoreactivity were present in 33 % (118/359), 50 % (181/359), 36 % (129/359), and 42 % (152/359), respectively. Patients with high expression of IL-4, IL-4R, and IL-13R had a lower frequency of lymph node metastases. Expression of IL-13 did not influence the frequency of lymph node metastases. However, high IL-13-immunoreactivity was associated with a better overall survival (p = 0.041). Expression of IL-4, IL-4R, or IL-13R did not influence survival. Multivariate analysis revealed that besides pT classification and tumor recurrence, IL-13 expression was an independent prognostic factor for overall survival. CONCLUSIONS: Expression of IL-4, IL-4R, and IL-13R are involved in the process of local metastases in colorectal cancer, while IL-13 expression has an impact on survival. These interleukins and their receptors may become attractive targets for the treatment of colorectal cancer.
PURPOSE:Interleukin-4 (IL-4) and interleukin-13 (IL-13) are anti-inflammatory and immunomodulatory cytokines which can influence cancer-directed immunosurveillance. Nothing is presently known about expression of these cytokines and their receptors (IL-4R and IL-13R) in colorectal cancer. The aim of this study was to characterize their expression in primary colorectal cancer specimens and to evaluate possible functions for this disease. METHODS: Expression of IL-4, IL-13, IL-4R, and IL-13R protein was characterized by immunohistochemistry in 359 patients with Union for International Cancer Control stage I-III colorectal cancer and evaluated by uni- and multivariate analysis for their prognostic relevance. RESULTS: All four proteins were expressed in colorectal cancer specimens. In the cancer cells, high IL-4, IL-13, IL-4R, and IL-13R immunoreactivity were present in 33 % (118/359), 50 % (181/359), 36 % (129/359), and 42 % (152/359), respectively. Patients with high expression of IL-4, IL-4R, and IL-13R had a lower frequency of lymph node metastases. Expression of IL-13 did not influence the frequency of lymph node metastases. However, high IL-13-immunoreactivity was associated with a better overall survival (p = 0.041). Expression of IL-4, IL-4R, or IL-13R did not influence survival. Multivariate analysis revealed that besides pT classification and tumor recurrence, IL-13 expression was an independent prognostic factor for overall survival. CONCLUSIONS: Expression of IL-4, IL-4R, and IL-13R are involved in the process of local metastases in colorectal cancer, while IL-13 expression has an impact on survival. These interleukins and their receptors may become attractive targets for the treatment of colorectal cancer.
Authors: Marcos Vinícius Macedo de Oliveira; Carlos Alberto de Carvalho Fraga; Ricardo Santiago Gomez; Alfredo Maurício Batista D Paula Journal: Head Neck Date: 2009-11 Impact factor: 3.147
Authors: Hak-Ling Ma; Matthew J Whitters; Bruce A Jacobson; Deborah D Donaldson; Mary Collins; Kyriaki Dunussi-Joannopoulos Journal: Int Immunol Date: 2004-06-07 Impact factor: 4.823
Authors: S Lebel-Binay; B Laguerre; F Quintin-Colonna; H Conjeaud; M Magazin; B Miloux; F Pecceu; D Caput; P Ferrara; D Fradelizi Journal: Eur J Immunol Date: 1995-08 Impact factor: 5.532
Authors: Vibha N Lama; Hiroaki Harada; Linda N Badri; Andrew Flint; Cory M Hogaboam; Andrew McKenzie; Fernando J Martinez; Galen B Toews; Bethany B Moore; David J Pinsky Journal: Am J Pathol Date: 2006-07 Impact factor: 4.307
Authors: Masaki Terabe; So Matsui; Jong-Myun Park; Mizuko Mamura; Nancy Noben-Trauth; Debra D Donaldson; Wanjun Chen; Sharon M Wahl; Steven Ledbetter; Bruce Pratt; John J Letterio; William E Paul; Jay A Berzofsky Journal: J Exp Med Date: 2003-12-01 Impact factor: 14.307
Authors: Abdul Arif Khan; Mohd Tashfeen Ashraf; Fahad M Aldakheel; Ayca Sayi Yazgan; Rana Zaidi Journal: Am J Transl Res Date: 2022-01-15 Impact factor: 4.060
Authors: Nicola Ingram; Emma L Northwood; Sarah L Perry; Gemma Marston; Helen Snowden; John C Taylor; Nigel Scott; D Timothy Bishop; P Louise Coletta; Mark A Hull Journal: Carcinogenesis Date: 2013-06-19 Impact factor: 4.944